Taizo Shimomura

Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease

Etsuro Mori, Nobutsugu Hirono, Hiroaki Yamashita et al. · American Journal of Psychiatry · 1997 · 170 citations

Distinct Roles of Ephrin-B2 Forward and EphB4 Reverse Signaling in Endothelial Cells

Koichi Hamada, Yuichi Oike, Yasuhiro Ito et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 88 citations

Analysis of a Chronic Myelogenous Leukemia Patient Vaccinated with Leukemic Dendritic Cells Following Autologous Peripheral Blood Stem Cell Transplantation

Shin‐ichiro Fujii, Kanako Shimizu, Koji Fujimoto et al. · Japanese Journal of Cancer Research · 1999 · 57 citations · Full text

<i><scp>IDH</scp>1</i> and <i><scp>IDH</scp>2</i> mutations confer an adverse effect in patients with acute myeloid leukemia lacking the <i><scp>NPM</scp>1</i> mutation

Shunichiro Yamaguchi, Eisaku Iwanaga, Kenji Tokunaga et al. · European Journal Of Haematology · 2014 · 47 citations

Hematological Malignancy, Chromatin, Transplantation +15

Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system

Tetsuzo Tauchi, Masahiro Kizaki, Shinichiro Okamoto et al. · Leukemia Research · 2010 · 39 citations

Hematological Malignancy, Seven-year Follow-up, Oncology +8